• Corpus ID: 53530205

Advances in endoscopic resection and radiofrequency ablation of early esophageal neoplasia

  title={Advances in endoscopic resection and radiofrequency ablation of early esophageal neoplasia},
  author={Frederike G. Van Vilsteren},
Lokale behandeling van vroege slokdarmkanker met de endoscoop is veilig en effectief. Nadat met endoscopische resectie (wegsnijden) het aangedane gebied in de slokdarm wordt verwijderd, dient enkele weken later het overige slijmvlies van de slokdarm te worden behandeld met radiofrequente ablatie (wegbranden). Dit blijkt uit het onderzoek van Frederike van Vilsteren naar de behandeling van de zogeheten Barrett-slokdarm. Hierbij is de slokdarm van binnen bekleed met maagslijmvlies in plaats van… 

Figures and Tables from this paper



Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial

In patients with BO ≤5 cm containing HGD/EC, SRER and ER/RFA achieved comparably high rates of CR-IM and CR-neoplasia, but SRER was associated with a higher number of complications and therapeutic sessions.

Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients

SRER of Barrett's oesophagus ≤5 cm containing early neoplasia appears to be an effective treatment modality with a low rate of recurrent lesions during follow-up.

Complete Barrett's Eradication Endoscopic Mucosal Resection: An Effective Treatment Modality for High-Grade Dysplasia and Intramucosal Carcinoma—An American Single-Center Experience

This is the largest American single-center experience demonstrating that CBE-EMR with close endoscopic surveillance is an effective treatment modality for BE with HGD/IMC management and patients considering endoscopic ablation should be counseled appropriately.

Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.

CBE-EMR is a safe and highly effective long-term treatment that should be offered to all patients with Barrett's esophagus with HGD and IMC.

Radiofrequency ablation for total Barrett's eradication: a description of the endoscopic technique, its clinical results and future prospects.

The technical background of radiofrequency ablation using the HALO system is explained, a summary of its current status, and speculate on possible future applications are given.

Increased risk for persistent intestinal metaplasia in patients with Barrett's esophagus and uncontrolled reflux exposure before radiofrequency ablation.

Uncontrolled, predominantly weakly acidic reflux despite twice-daily proton pump inhibitor therapy before RFA increases the incidence of persistent intestinal metaplasia after ablation in patients with BE.

Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae--a multicenter retrospective cohort study.

EMR for ESCC that invades the muscularis mucosa has curative potential as a minimally invasive treatment option for esophageal squamous cell carcinoma and survival after EMR is investigated.